Provident Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Provident Investment Management's BIIB Position: Q1 2019 in Review
Provident Investment Management sold out of Biogen (BIIB) in Q1 2019, closing a stake of 82,099 shares — an estimated $24.7M sold.
Provident Investment Management first reported a position in BIIB in Q3 2015 and held it in 14 quarters. The position peaked at $29.9M in Q3 2018. 1,085 funds tracked by Wall St. Rank hold BIIB as of Q1 2019.
- Provident Investment Management reported no remaining Biogen position as of Q1 2019 after selling out during the quarter.
- Provident Investment Management sold 82,099 Biogen shares in Q1 2019, an estimated $24.7M.
- Provident Investment Management first reported a position in Biogen in Q3 2015 and held it in 14 quarters.
- Provident Investment Management's Biogen position peaked at $29.9M in Q3 2018.
- 1,085 funds tracked by Wall St. Rank held Biogen as of Q1 2019.
Based on Provident Investment Management's 13F filing for Q1 2019, filed 13 May 2019.